The Tat system transports folded proteins across the bacterial cytoplasmic membrane and the thylakoid membrane of plant chloroplasts. In Escherichia coli substrate proteins initially bind to the integral membrane TatBC complex which then recruits the protein TatA to effect translocation. Overproduction of TatBC and the substrate protein SufI in the absence of TatA led to the accumulation of TatBC-SufI complexes that could be purified using an affinity tag on the substrate. Three-dimensional structures of the TatBC-SufI complexes and unliganded TatBC were obtained by single-particle electron microscopy and random conical tilt reconstruction. Comparison of the structures shows that substrate molecules bind on the periphery of the TatBC complex and that substrate binding causes a significant reduction in diameter of the TatBC part of the complex. Although the TatBC complex contains multiple copies of the signal peptide-binding TatC protomer, purified TatBC-SufI complexes contain only 1 or 2 SufI molecules. Where 2 substrates are present in the TatBC-SufI complex, they are bound at adjacent sites. These observations imply that only certain TatC protomers within the complex interact with substrate or that there is a negative cooperativity of substrate binding. Similar TatBC-substrate complexes can be generated by an alternative in vitro reconstitution method and using a different substrate protein.
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membrane protein ͉ Escherichia coli ͉ blue native PAGE ͉ single particle electron microscopy T he twin arginine translocation (Tat) system transports folded proteins across the cytoplasmic membrane of prokaryotes and the thylakoid membrane of plant chloroplasts (1) (2) (3) (4) . The Tat pathway is involved in a wide range of cellular functions including biosynthesis of respiratory and photosynthetic electron transfer chains, formation of the bacterial cell envelope, bacterial motility, establishment of the nitrogen-fixing symbiosis, quorum sensing, and bacterial pathogenesis (5, 6) . The task faced by the Tat system is mechanistically very challenging because it involves transporting large protein substrates of differing size and surface properties across a membrane while maintaining the membrane permeability barrier. Proteins are targeted to the Tat system by N-terminal signal peptides bearing a consensus amino acid motif that contains consecutive arginine residues (7, 8) . Transport through the Tat pathway is energized by the transmembrane proton electrochemical gradient (9) .
The minimal components of the Tat system in the bacterium Escherichia coli are the 3 integral membrane proteins TatA, TatB, and TatC (10) (11) (12) (13) . TatB and TatC are found in a large complex containing multiple copies of each of the 2 constituent subunits (14) (15) (16) . This TatBC complex acts as the membrane receptor of the Tat system with the twin arginine motif of the substrate signal peptide being specifically recognized by the TatC subunit (17) (18) (19) . TatA forms homo-oligomeric ring-like structures of variable size that are likely to constitute the protein translocating channels of the Tat system (20, 21) . Current models of the Tat transport cycle propose that substrate proteins initially bind to TatBC which then recruits TatA to form the active translocation complex (18, (21) (22) (23) (24) .
This study reports the trapping and isolation of E. coli TatBC-substrate complexes and their structural characterization by electron microscopy. Structures of the unliganded TatBC complex were also determined for comparison. This study presents 3-dimensional structural information on TatBC complexes and provides significant insights into the way the TatBC complex interacts with substrate proteins. TatBC-substrate Com- plexes. Complexes between TatBC and the native E. coli Tat substrate SufI (a cell division protein; 25) were generated in vivo by coordinately overproducing SufI and TatBC in a strain lacking other Tat components. The TatBC-SufI intermediate accumulates under these conditions because it is unable to progress further through the transport cycle in the absence of TatA (and its paralogue TatE). The SufI precursor protein was engineered with a C-terminal hexahistidine tag to allow the specific isolation of substrate-bound TatBC complexes.
Results

Isolation and Biochemical Characterization of
Membranes from cells overproducing TatBC and SufI His were solubilized in digitonin, a detergent that is known to maintain the integrity of the TatBC complex (16) . The resulting soluble extract was subjected to Ni 2ϩ -affinity chromatography. Fractions eluted from the affinity matrix with an imidazole gradient contained SufI His , TatB, and TatC (Fig. S1 ). Since only the SufI protein possesses a polyhistidine affinity tag it can be inferred that the TatB and TatC proteins are retained by the column because they are bound to SufI. A control experiment confirmed that TatB and TatC did not bind to the Ni 2ϩ -affinity column in the absence of SufI His .
The TatBC-SufI His complexes present in the Ni 2ϩ -affinity column eluant were separated from free SufI His by size exclusion chromatography ( Fig. 1 ). TatB and TatC coeluted with SufI His in a peak corresponding to an apparent molecular mass of 670 kDa. N-terminal sequencing showed that the unprocessed (but lacking the initiator methionine) precursor form of SufI His was present in these TatBC-SufI His complexes. Free SufI His was found in a peak with an apparent molecular mass of Ͻ50 kDa corresponding to the elution position of mature SufI His . Two SufI degradation products previously identified as arising from proteolysis of a long surface loop (25) copurified with free SufI His . The SufI protein present in the TatBC-SufI His complexes does not exhibit this proteolytic event suggesting that access to this region of SufI His is protected in the complexes. The composition of the TatBC-SufI His preparation was analyzed by blue native-PAGE ( Fig. 2A) . Three species with apparent molecular masses of 500, 540, and 580 kDa were resolved. Insight into the composition of the 3 species was provided by subjecting the sample to a second Ni 2ϩ -affinity chromatography experiment. The 500-kDa species did not bind to the column and was found to contain TatB and TatC but not SufI His (Fig. 2 B and  C) . The 500-kDa complex, therefore, corresponds to TatBC that has released SufI His subsequent to the first Ni 2ϩ -affinity step. This dissociation can be inferred to be an ongoing process during isolation because the 500 kDa species was also found in the fraction subsequently eluted from the column with 150 mM imidazole (Fig. 2D) . The 500-kDa TatBC complex has a higher apparent molecular mass than the TatBC His complex purified in the same detergent (Fig. 2 A) , suggesting that the presence of a hexahistidine tag has a significant effect on the mobility of the TatBC complex under blue native-PAGE. The SufI Hiscontaining complexes bound to the second Ni 2ϩ -affinity column could be partially resolved by step elution with different concentrations of imidazole ( Fig. 2 B and D) . Complexes eluting at a lower imidazole concentration contained predominantly the 540-kDa species, whereas those eluting at a higher imidazole concentration corresponded to the 580-kDa species (Fig. 2D) . The higher affinity of the 580-kDa species for the Ni 2ϩ -affinity column suggests that this complex contains more hexahistidine tags, and thus more copies of SufI His , than the 540-kDa species. Because the 500-kDa species does not contain SufI His , and the molecular mass of the SufI His precursor is 53 kDa, the 540-kDa species is most likely to bind 1, and the 580-kDa species 2, SufI His molecules.
Electron Microscopy of TatBC and TatBC-Substrate Complexes. Samples of the TatBC-SufI His complexes were analyzed by singleparticle electron microscopy. For comparison TatBC His complexes purified by a similar protocol were also analyzed. For both samples, the particles had a preferred orientation on the carbon support. A random conical tilt approach (26) was therefore used to determine 3-D maps of TatBC His and TatBC-SufI His . In total, 2,885 particles were selected from 11 tilt pairs of the TatBC sample and 5,682 particles from 35 tilt pairs of the TatBC-SufI preparation.
TatBCHis. The particles from the TatBC His sample were sorted into 150 classes, some of which are shown in Fig. 3 A and B. The particles are slightly elongated, with a maximum length of 10-12 nm and a spiky border ( Fig. 3 A and B) . Three-dimensional maps of the different classes were calculated and similar ones were combined. This processing resulted in 2 3-D maps, a smaller one (Fig. 4A, 1 ,358 images) derived from the data shown in Fig. 3A , and a larger one (Fig. 4B, 911 images) from the data in Fig. 3B . Both maps have a roughly hemispherical shape. The isosurface threshold was chosen to include all of the strong density but exclude noise features. These surfaces enclose volumes consistent with the molecular mass determined by blue native-PAGE analysis (Fig. 2 A) . At the threshold shown, the bigger 3-D map has a molecular mass of approximately 420 kDa and the smaller 3-D map a molecular mass of approximately 380 kDa, assuming a protein density of 844 Da/nm 3 .
The approximate 50-Å height of the TatBC His hemisphere ( Fig.  4 A and B) is compatible with the thickness of a lipid bilayer. We propose that TatBC is positioned in the membrane such that the plane of the TatBC His hemisphere is parallel to the plane of the lipid bilayer as shown in the right hand side of Fig. 4A . Only in this orientation would the face of the particle contacting the carbon support be distinct from the opposite surface (cytoplasmic versus periplasmic face or vice versa), leading to the observed unique orientation of the particles on the carbon support.
TatBC-SufIHis Complexes. Raw images of the TatBC-SufI His preparation showed particles of Ϸ10-nm diameter, some of which had small protrusions ( Fig. S2 A and B) . The images of the TatBCSufI His complex were classified into 3 approximately equal subsets on the basis of these additional features. One subset (1,556 images) ( Fig. 3C ) strongly resembled the TatBC His complex alone ( Fig. 3 A  and B ). These particles are likely to be TatBC with no substrate bound. Because these TatBC complexes do not possess a His-tag it can be inferred that the presence of a His-tag on the C terminus of TatC does not change the overall structure of the TatBC complex. The second subset (1,297 images) displayed a 9.5-11-nm diameter round density with a single protrusion of approximately 4.5 nm in length (Fig. 3D) . The third subset (1,284 images) displayed a similar round density but with 2 protrusions (Fig. 3E ). Since the protrusions are approximately the size of a SufI monomer, it is very likely that each protrusion corresponds to 1 SufI His molecule and that the round central density is TatBC. Biochemical experiments (above) also suggested a distribution of TatBC complexes with 0, 1, or 2 SufI His molecules bound. It is notable that in the complexes with 2 protrusions, the protrusions are always closely adjacent (Fig. 3E) . Three-dimensional maps were calculated for TatBC-SufI His complexes with 1 or 2 SufI bound using all of the data for each subset. These structures are displayed in Fig. 4 C and D in the same orientation relative to the support film as the TatBC His complexes in Fig. 4 A and B. Density thresholds were chosen for the 3-D maps so that the mass of each protrusion corresponds to the 50-kDa mass of SufI. On this basis the TatBC component of the complexes has a molecular mass of approximately 350 kDa. Examination of individual class averages or the final 3-D maps shows that the TatBC part of the substrate complexes is noticeably smaller than TatBC alone (isolated either as TatBC His or in the unbound fraction of TatBC-SufI His ) (Fig. 3 A-C, Fig. 4 A and B, and The X-ray structure of SufI (25) was fitted into the protrusions of the TatBC-SufI His complexes with the N terminus, containing the Tat signal peptide, contacting the TatBC complex (Fig. 4 E  and F) . The density assigned to SufI accommodates the X-ray structure very well in this orientation and is entirely consistent with SufI being in the fully folded state in the complex. The close approach of the SufI His densities to the TatBC core suggests that the 27-amino acid SufI signal peptide is predominantly buried in the adjacent TatBC complex. The 3-D maps of the TatBC His and TatBC-SufI His complexes have resolutions of 3.5-4.5 nm. Central sections of the maps show that all of the 3-D structures have an internal cavity ( Fig. 4G and Fig. S2 C-F) . No connectivity between the internal cavity and the surface of the particles is apparent at the current resolution.
Characterization of TaBC-CueOHis Complexes Produced by In Vitro
Reconstitution. To assess the generality of the biochemical and structural conclusions derived from our studies of TatBC-SufI His complexes, we generated and characterized a second type of TatBC-substrate complex. This complex contained a different substrate protein, the native E. coli Tat substrate CueO [a putative Cu(I) oxidase; (27) ], prepared by an alternative in vitro reconstitution method. Inverted inner membrane vesicles (IMVs) were isolated from a strain overproducing TatBC but lacking other Tat components. The IMVs were then mixed with purified CueO His precursor in the presence of ATP to generate a transmembrane proton electrochemical gradient via ATP synthase. The IMVs were solubilized in digitonin and TatBCCueO His complexes were purified in the same way as the TatBC-SufI His complexes (Fig. 2E) . Analysis of the preparation by blue native-PAGE revealed complexes with molecular masses of 500 and 540 kDa (Fig. 2F) . By analogy to the TatBC-SufI His preparation, these 2 species correspond to TatBC and TatBC bound to a single molecule of CueO His . Control experiments using a transport-inactive variant of CueO His in which a lysine pair is substituted for the twin arginine residues of the signal peptide confirmed that a functional signal peptide was required to isolate TatBC-CueO His complexes. The complexes in the TatBC-CueO His sample were analyzed by single-particle electron microscopy. From 26 CCD images, 4,998 particles were selected and processed. The dataset was divided into 2 subsets. One resembled TatBC alone. The other displayed a 10-11-nm diameter round density with a single protrusion of approximately 4.5 nm in length (Fig. 3F) resembling the TatBC-SufI His complexes with 1 SufI bound (Fig. 3D) . The size of the protrusion is consistent with the structure of CueO determined by X-ray crystallography (28) . Only 485 particles (Ͻ10%) show the protrusion bound to the TatBC particle. This observation is consistent with the low staining intensity of the 540-kDa species relative to the 500-kDa species on blue native-PAGE (Fig. 2F ). As seen with the TatBC-SufI His complexes, the density attributed to TatBC in the TatBCCueO His complexes is smaller than either of the substrate-free TatBC His complexes.
As a further control we determined the 3-D structures of TatA His complexes that had also been purified in digitonin (Fig.  S3 and Fig. S4 ). These TatA structures are not significantly different from those previously determined for TatA in the detergent C 12 E 9 (19) even though blue native PAGE only resolves distinct complexes for the latter preparation [compare Fig. S3B with Fig. 1E in ref. 19 ]. This observation shows that the gross structure of the TatA complex is not detergent-specific. Importantly the morphology of TatA in digitonin is clearly distinct from that of the TatBC complex in the same detergent, with the TatA complexes having a considerably larger internal cavity that is open to 1 face of the particle.
Discussion
We have used single-particle electron microscopy to obtain 3-D structures of the TatBC complex both in isolation and bound to water-soluble substrate proteins. Importantly the structures of TatBC-substrate complexes formed by 2 different approaches (in vivo-assembled TatBC-SufI His and in vitro-assembled TatBCCueO His ) revealed the same location of substrate on the TatBC complex and the same structural change on substrate binding in the TatBC part, arguing for the generality of our observations.
The TatBC-substrate structures show that the substrate proteins are located at the periphery of the TatBC complex. Although there is a cavity in the interior of the TatBC particle ( Fig. 4G and Fig. S2 C and D) , it is too small to accommodate a substrate of the size of SufI or CueO. In addition, the cavity has no obvious opening to the surface of the particle, and there is no evidence from the substrate-bound structures that the cavity either dilates or contains substrate (Fig. 4G and Fig. S2 E  and F) . Therefore, the structural data give no indication that the substrate molecule enters the interior of the TatBC complex during transport. Instead, as anticipated by some mechanistic models (17, 20, 29) , the peripheral location of the substrate would be appropriate for interaction with TatA units recruited from the surrounding membrane to form the translocation pathway.
Comparison of the averaged images of TatBC with and without bound substrate shows that the TatBC part undergoes a major structural reorganisation with TatBC bound to substrate being significantly smaller than the unliganded complex ( Fig. 3  A-C, Fig. 4 A and B Fig. 4C and D, and Fig. S2 E and F) . This difference cannot be accounted for solely by changes in subunit packing-the smaller structure does not appear more densely packed-and therefore implies a loss of subunits from the TatBC complex when substrate is bound. There is already considerable evidence that both the oligomeric state of TatA and its interaction with TatBC alter during the transport cycle (17, 18, (21) (22) (23) (24) , so our observations that TatBC can also change size suggest that protein-protein interactions in the entire Tat system are highly dynamic. It has been proposed that detergent extraction alters the equilibrium between TatA monomer and oligomer states found in the native membrane environment (20) and this possibility must also be borne in mind when considering the TatBC structures. The observed reorganization of TatBC upon substrate binding is consistent with the proposal that TatBC undergoes a substrate-dependent structural change to allow recruitment of TatA (17) . Structural change in TatBC has also been invoked to explain a pmf-dependent tightening of the substrate-TatBC interaction in the thylakoid Tat system (30) .
The TatBC complex contains multiple copies of the signal peptide-binding TatC protomer and would, therefore, be anticipated to contain multiple substrate binding sites. However, not more than 2 bound substrate molecules are seen in the TatBCSufI His structures and only a single bound substrate is observed in the TatBC-CueO His structures. What could be the explanation for this substoichiometric occupancy of potential substrate binding sites? The concentration of CueO His used to generate the TatBC-CueO His complexes (18 M) is significantly in excess of the apparent affinity of the TatBC complex for CueO His as determined by transport competition experiments (K i Ϸ 0.1 M; Fig. S5 ). Similarly, during in vivo generation of TatBC-SufI His complexes excess precursor protein accumulates in the soluble phase. Formation of TatBC-substrate complexes in our experiments should, therefore, be occurring close to substrate saturation and we would expect all functional substrate binding sites in TatBC to be occupied at the start of the purification procedure. With this scenario in mind possible explanations for the substoichiometric occupancy of substrate binding sites by TatBC are that the other binding sites are either not functional or bind substrate too weakly to allow isolation. There are 2 possible models to account for this behavior. In the first model, inherent asymmetry within the structure of the TatBC complex allows functional binding sites at only 1 or 2 specific positions. In the second model, all substrate binding sites are equally available but substrate binding is anti-cooperative. In the latter model binding of a substrate molecule at a randomly selected site induces a concerted structural change within the TatBC complex (as observed) and this change inhibits the interaction of substrate molecules with the remaining binding sites. Cooperative interactions between substrate binding sites in TatBC have previously been inferred for the chloroplast Tat system (31) .
Although models invoking nonequivalence of substrate binding sites can explain the observed substoichiometric binding of substrate to TatBC, it is important to note that the identification of substrate-free TatBC complexes in the TatBC-substrate preparations (Fig. 2 A-D and F) shows that some TatBC-substrate complexes release all bound substrate molecules during purification. This observation raises the possibility that all substrate binding sites in TatBC are equivalent and functional but that the majority of the bound substrate molecules dissociate from the TatBC-substrate complex during purification. We do not favor this explanation for the low occupancy of the TatBC substrate binding sites for 2 reasons. First, where 2 SufI molecules are bound to TatBC they bind at adjacent sites (Fig. 3E) . In other words, the second binding site is not randomly selected relative to the first. This pattern of binding would be consistent with 1 region of the TatBC complex being specialized for substrate binding. It would also be consistent with anti-cooperative binding of substrate molecules if the inhibitory effects of substrate binding at a first site are less severe at immediately adjacent sites than at more distal binding sites. By contrast, nonrandom substrate binding is incompatible with a model invoking identical noncooperative binding sites. Second, electron microscopic analysis shows that TatBC complexes with 2 SufI molecules bound are as abundant as TatBC complexes with 1 SufI molecule bound whereas complexes containing Ͼ2 SufI molecules are not detected. Such a distribution is not easy to reconcile with substrate binding to equivalent sites but is consistent with the binding sites being of variable affinity. In this context it is worth noting that binding of a single substrate molecule is sufficient to induce structural reorganization of TatBC and that no major additional reorganization of the complex occurs on binding a second molecule of substrate. This correlation suggests that TatBC is designed to respond in a concerted fashion to association with a single substrate molecule and that substrate binding to additional sites is not mechanistically relevant. Concerted structural reorganization would provide a way by which substrate binding at 1 site could alter the affinity of other substrate binding sites. It could also indicate that the whole TatBC complex has to change conformation to allow interaction with TatA.
In complexes containing 2 SufI His molecules the adjacent SufI His molecules are positioned Ϸ50°apart on the circumference of TatBC. Assuming each substrate binding site is formed by a single TatC protomer, and that these protomers are arranged evenly around the TatBC complex, it can be inferred that there are 7 copies of TatC in the substrate-bound TatBC complex. Since TatB and TatC are present at equimolar ratios in the TatBC complex (14) , 7 copies of TatB should also be present. This stoichiometry gives a total molecular mass for the substratebound complex of approximately 350 kDa which is in good agreement with the mass (Ϸ350 kDa) estimated from the 3-D reconstructions.
Materials and Methods
Sample Production. Plasmid construction, overproduction and purification of CueOHis, TatBCHis, and TatBC-SufIHis, production of TatBC-IMVs, and general protein methods are detailed in SI Methods. In vitro reconstitution of TatBCCueOHis complexes was undertaken as follows. One-half milliliter of a 15 mg protein/mL solution of TatBC-IMVs was incubated with 30 L of a stock ATP regenerating system (giving final concentrations of 2.5 mM ATP, 0.5 mM GTP, 0.5 mM CTP, 0.5 mM UTP, 8 mM creatine phosphate, 40 g/mL creatine phosphokinase, and 2 mM DTT, pH 7.0) for 15 min at 30°C. A 2.8 mg protein/mL solution of purified CueO His (0.3 mL) was added and incubation continued for another 30 min. The IMVs were then solubilized by adding an equal volume of 2% (wt/vol) digitonin in 20 mM Mops, pH 7.2, 200 mM NaCl, and 60 mM imidazole, and incubating for 1 h at 4°C. TatBC-CueO His complexes were purified from the solubilized extract employing the same protocol that was used to isolate the TatBC-SufI His complexes (SI Methods).
Transmission Electron Microscopy. Samples of the TatA His, TatBCHis, TatBCSufI His, and TatBC-CueOHis preparations with final concentrations of 0.01 mg/mL, 0.015 mg/mL, 0.01 mg/mL, and 0.013 mg/mL, respectively were negatively stained with 2% (wt/vol) uranyl acetate on glow discharged, continuous carbon-coated 300 mesh copper grids (Agar Scientific). Electron micrographs of the TatAHis, TatBCHis, and TatBC-SufIHis samples were recorded with low dose on Kodak SO-163 electron image film using a Tecnai T12 microscope at 120 kV at a magnification of 42,000 ϫ. Tilt pairs were collected with the first micrograph at a nominal tilt angle of Ϫ50°and the second at 0°. The average defocus was approximately 2 m for the tilted and 1 m for the untilted micrographs for TatA His and TatBCHis and 1.5 m for TatBC-SufIHis. The average defocus was approximately 1 m for the untilted micrographs of TatBCCueO His. Micrographs were digitized on a Zeiss SCAI scanner at a pixel size of 7 m, corresponding to 1.667 Å on the specimen. Subsequently, adjacent pixels were 3 ϫ 3 averaged to yield a pixel size of 5 Å. CCD images of the TatBC-CueO His sample were recorded with low dose on a 4 k ϫ 4 k Gatan CCD camera using a Tecnai F20 at 200 kV, at a magnification of 68,100ϫ, corresponding to a pixel size of 2.22 Å. Subsequently, adjacent pixels were 2 ϫ 2 averaged to yield a pixel size of 4.44 Å.
Image Processing. The tilted images of the TatBC His and TatBC-SufIHis samples were corrected for the effects of the contrast transfer function (CTF) by phase flipping, taking into account the defocus gradient across the micrographs and the position of each particle. Images of the TatA His, TatBCHis, and TatBC-SufIHis samples were processed using SPIDER version 11.12 and 15.06 (32) . Threedimensional reconstruction was performed by the random conical tilt method (26) , with some scripts adapted from ones provided by N. Boisset and R. Trujillo. Equivalent particles from tilted and untilted images were identified and selected using the ''tilted particles'' option in WEB (32) , and used for determination of the tilt geometry for each micrograph. The particles were windowed into 64 ϫ 64 pixel boxes for TatBC His and TatBC-SufIHis, and into 100 ϫ 100 pixel boxes for TatA His, filtered, normalized and centered with reference to a circular mask. To avoid reference bias, the first averages were calculated from the untilted images using reference-free alignment (33) and classification. These class averages were then used as initial references for iterative multireference alignment (32) . Then the tilted images were grouped and rotationally aligned according to the classification and in-plane orientations of the untilted images. 3D maps were then calculated for each of the tilted image classes (26) . Visually similar 3D maps with high mutual crosscorrelation coefficients were aligned and merged. The resolutions of the final 3D maps were determined by Fourier shell correlation with the 0.5 correlation criterion. 3D maps were contoured at thresholds of 1.1-1.5 sigma. The X-ray structure of the SufI monomer (25) was manually fitted into the 3-D maps with Chimera (34) .
Particles from the TatBC-CueO His sample were selected from CCD images, windowed into 70 ϫ 70 pixel boxes using EMAN/BOXER (35) , and processed as for the untilted TatBC His and TatBC-SufIHis complexes.
